David Katz Amgen Inc Transaction History

Matrix Asset Advisors Inc

$1.02 Billion
Q3 2025

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Amgen Inc stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 106,231 shares of AMGN stock, worth $36.3 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

106,231

Previous 101,598 4.56%

Holding current value

$36.3 Million

Previous $28.4 Million 5.68%

% of portfolio

2.94%

Previous 3.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	BUY	$271.18 - $309.22 $1.26 Million - $1.43 Million	4,633 Added 4.56%	106,231 $30 Million
Q2 2025 Jul 25, 2025	BUY	$262.28 - $309.85 $1.12 Million - $1.33 Million	4,284 Added 4.4%	101,598 $28.4 Million
Q1 2025 Apr 22, 2025	BUY	$258.59 - $327.36 $1.11 Million - $1.41 Million	4,292 Added 4.61%	97,314 $30.3 Million
Q4 2024 Jan 22, 2025	BUY	$258.78 - $328.31 $11.8 Million - $15 Million	45,573 Added 96.05%	93,022 $24.2 Million
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $736,633 - $803,301	2,381 Added 5.28%	47,449 $15.3 Million

Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $1.01 Million - $1.23 Million	3,845 Added 9.33%	45,068 $14.1 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $251,931 - $304,112	-937 Reduced 2.22%	41,223 $11.7 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $35,798 - $40,384	140 Added 0.33%	42,160 $12.1 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $1.34 Million - $1.66 Million	-6,130 Reduced 12.73%	42,020 $11.3 Million
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $441,181 - $521,688	2,059 Added 4.47%	48,150 $10.7 Million
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $592,021 - $721,574	2,622 Added 6.03%	46,091 $11.1 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $3.53 Million - $4.49 Million	-15,425 Reduced 26.19%	43,469 $0
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $154,877 - $174,673	690 Added 1.19%	58,894 $13.3 Million
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $114,432 - $127,343	-496 Reduced 0.84%	58,204 $14.2 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $1.07 Million - $1.18 Million	4,878 Added 9.06%	58,700 $14.2 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $4.45 Million - $5.1 Million	22,400 Added 71.29%	53,822 $12.1 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $758,440 - $888,605	3,573 Added 12.83%	31,422 $6.68 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $2.62 Million - $2.91 Million	11,216 Added 67.43%	27,849 $6.79 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $3.69 Million - $4.3 Million	16,633 New	16,633 $4.14 Million
Q1 2017 May 10, 2017	SELL	N/A	-3,924 Closed	0 $0
Q3 2016 Nov 07, 2016	BUY	N/A	3,924	3,924 $655,000

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track David Katz's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Account